Mutations in KRAS and BRAF V600E are among the most frequent mutations in advanced stages of dMMR/MSI-H CRC, and they are each found in approximately 30% of the cases compared to frequencies of around 40% and 8%, respectively, of pMMR/MSS CRC cases [2,40]. This evidence concerns the gene KRAS and colorectal carcinoma.